In addition, uremic serum, similarly to what happens in patients with CKD presented low levels of 25-vitamin D. The novelty of our study, however, was demonstrating that 25-vitamin D was capable to reduce TLR-4, MCP-1, and cathelicidin in a uremic environment. This evidence concerns the gene TLR4 and chronic kidney disease.